Lv1
30 积分 2023-06-05 加入
EGFR p.V774M/p. the S768I Compound Mutation in NSCLC Is a Good Prognostic Marker for IPHC- and Furmonertinib-Based Treatment: A Case Report
8天前
已完结
Reciprocal regulation of TNF receptor 1-mediated signaling and inflammatory damages by MARCH2 and USP22
9天前
已完结
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial
12天前
已完结
Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case report
12天前
已完结
Impact of SERPINA3 on the Prognostic Role of KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients Receiving Gemcitabine-Based Treatment: A Cross-Sectional Study
1个月前
已完结
Cancer cachexia: A tumor-driven disorder of whole-body homeostasis
2个月前
已完结
CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients
2个月前
已完结
Survival analysis and prognostic factors in advanced NSCLC harboring EGFR PACC mutations: A multicenter retrospective study
4个月前
已完结
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
4个月前
已完结
Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer
4个月前
已完结
皖公网安备34019202002308
